Skip to main content
NGVT
NYSE Industrial Applications And Services

Ingevity 10-Q: Q3 EPS $1.41, EBITDA Outlook Narrowed to $385-$395M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Neutral
Importance info
7
Price
$63.71
Mkt Cap
$2.19B
52W Low
$45.85
52W High
$79.285
52W Position info
39% above low
Off High info
20% below high
Rel. Volume info
3.2× avg
Market data snapshot near publication time

NGVT sits 39% above its 52-week low of $45.85 on elevated volume (3.2× avg).

Summary

Ingevity's Q3 10-Q confirms $1.41 diluted EPS and $305.1 million of sales, narrows 2026 adjusted EBITDA to $385-$395 million, and shows nine-month operating cash flow cut to $83.4 million by the $113.2 million BASF settlement.


Key Events · Earnings and Guidance · NGVT

  • Q3 Earnings Confirmed in 10-Q

    Net sales of $305.1 million, net income of $49.3 million and diluted EPS of $1.41; nine-month net income was $144.4 million versus a $82.5 million loss a year earlier.

  • EBITDA Outlook Narrowed

    Full-year 2026 adjusted EBITDA guidance narrowed to $385-$395 million, holding the midpoint of the prior $380-$400 million range; net sales expected at roughly $1.1 billion.

  • Cash Flow Hit by BASF Payment

    Nine-month operating cash flow fell to $83.4 million from $234.1 million, driven by a $113.2 million litigation settlement payment made April 1, 2026.

  • Buybacks Continue

    Repurchased $126.3 million of stock in nine months (1,804,168 shares at $69.44 average), leaving $172.2 million unused under the 2022 authorization.


Analysis · NGVT · Industrial Applications And Services

The 10-Q puts full numbers behind the November 4 earnings release. Q3 net income was $49.3 million, or $1.41 diluted, on net sales of $305.1 million, and nine-month net income swung to $144.4 million from a $82.5 million loss a year earlier that carried a $183.8 million goodwill impairment. Cash is the bigger story: nine-month operating cash flow fell to $83.4 million from $234.1 million, mostly because of the $113.2 million BASF litigation settlement paid on April 1, 2026. Management narrowed 2026 adjusted EBITDA to $385-$395 million while keeping the midpoint of the prior $380-$400 million range, and it is still working off roughly $20 million of stranded costs from the divestitures, having eliminated about 65% on an annualized run-rate basis through Q3. Buybacks stayed aggressive at $126.3 million for nine months, with $172.2 million left on the authorization.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NGVT was trading at $63.71 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $45.85 to $79.29. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NGVT - Latest Insights

NGVT
Nov 04, 2026, 8:25 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $73.31
Real-time Price: $55.96 info
Change: -$17.35 (-24%) info
Market Cap: $1.89B info
NGVT
Nov 04, 2026, 4:15 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $73.73
Real-time Price: $55.96 info
Change: -$17.77 (-24%) info
Market Cap: $1.89B info
NGVT
Jul 30, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $70.19
Real-time Price: $55.96 info
Change: -$14.23 (-20%) info
Market Cap: $1.89B info
NGVT
Jul 29, 2026, 5:19 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $70.62
Real-time Price: $55.96 info
Change: -$14.66 (-21%) info
Market Cap: $1.89B info
NGVT
May 07, 2026, 4:26 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $74.07
Real-time Price: $55.96 info
Change: -$18.11 (-24%) info
Market Cap: $1.89B info